Hoth Therapeutics, Inc. RKTO · Stock Open Hoth Therapeutics, Inc. in new tab
Hoth Therapeutics, Inc. Analysis (RKTO)
Is Hoth Therapeutics, Inc. a good investment? Hoth Therapeutics, Inc. (RKTO) is currently trading at 0.6910 USD.
Earnings Schedule: Hoth Therapeutics, Inc. is expected to release its next earnings report on Dec. 2, 2026.
Investor FAQ
Does Hoth Therapeutics, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Hoth Therapeutics, Inc.?
Hoth Therapeutics, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Dec. 2, 2026. The company currently has a trailing EPS of -0.78.
Company Profile
Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure. It also develops AI chip and memory hardware engineered for orbital and high-radiation environments, including next generation nanomagnetic AI chip technology. It offers semiconductor infrastructure built around nanomagnetic, and spintronic computing technologies designed to address these constraints at the hardware level. It also offers non-volatile nanomagnetic matrix multiplier architecture for machine learning and AI acceleration and spintronic memory technology with potential applications across defense systems, autonomous platforms, resilient edge compute, and radiation-tolerant space computing. The company was formerly known as Hoth Therapeutics, Inc. and changed its name to Rocket One Inc. in May 2026. The company was incorporated in 2017 and is based in Hoboken, New Jersey.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 26, 2022 | 1:25 |
Community Discussion